NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (OTC PINK: ZYXIQ). Shareholders who purchased shares of ZYXIQ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form-2/?id=184880&from=3 CLASS PERIOD: February 25, 202 ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] On March 11, 2025, after the market closed, Zynex re ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - March 26, 2026) ...

ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements Accessibility StatementSkip Navigation Lawsuit Alleges Systematic "Oversupplying" Scheme and Overbilling of Government Payors; Firm Reminds Investors of April 21 Lead Plaintiff Deadline. SAN FRANCISCO, March 24, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been fi ...

ZYXI ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements Accessibility StatementSkip Navigation Lawsuit Alleges Systematic "Oversupplying" Scheme and Overbilling of Government Payors; Firm Reminds Investors of April 21 Lead Plaintiff Deadline. SAN FRANCISCO, March 20, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Z ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Faruqi ...

Core Viewpoint - A securities class action lawsuit has been filed against Zynex, Inc. and its former executives due to a significant overbilling scheme that led to the company's delisting and Chapter 11 bankruptcy filing [1][2]. Summary of Allegations - The lawsuit alleges that Zynex engaged in a deceptive "oversupplying" scheme, inflating revenue by shipping excessive medical supplies to patients, which was not based on legitimate medical necessity [2][6]. - The complaint claims that Zynex's growth was misrepresented, attributing it to fraudulent practices rather than genuine market demand [2][3]. - Zynex allegedly lacked effective internal controls to prevent manipulation of supply orders and billing data [6]. Financial Impact - Following the exposure of the overbilling practices, Zynex was forced to forfeit over $85 million to resolve fraud allegations and subsequently filed for Chapter 11 bankruptcy, resulting in a near-total loss for common equity holders [6]. Legal Proceedings - The lawsuit, titled Beidel v. Sandgaard, was filed in the U.S. District Court for the District of Colorado, covering the Class Period from February 25, 2021, to December 15, 2025 [2][4]. - Former CEO Thomas Sandgaard and former COO Anna Lucsok were indicted for health care and securities fraud, leading to their removal from the company [6]. Important Dates - Investors who purchased Zynex common stock during the Class Period have until April 21, 2026, to request appointment as Lead Plaintiff in the lawsuit [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Zynex, Inc. due to allegations of securities law violations, encouraging affected investors to contact the firm directly [2][4]. Group 1: Allegations Against Zynex - The complaint alleges that Zynex and its executives made false and misleading statements, including shipping products in excess of need, which inflated revenue [4]. - It is claimed that Zynex's practice of filing false claims attracted scrutiny from insurers, particularly Tricare, which is Zynex's largest customer, accounting for 20-25% of revenue [4][5]. - The lawsuit indicates that Zynex's aggressive sales strategies prioritized order growth over compliance with industry regulations, leading to potential adverse consequences such as removal from insurer networks [4]. Group 2: Financial Impact and Stock Performance - On March 11, 2025, Zynex reported a significant revenue shortfall due to slower payments from payers, with Tricare temporarily suspending payments for claim reviews [5]. - Following this news, Zynex's stock price fell by $3.59 per share, or 51.3%, closing at $3.41 per share on March 12, 2025 [6]. - On July 31, 2025, Zynex acknowledged non-compliance with industry regulations and announced a leadership change, which led to a further decline in stock price from $2.23 to $1.26 per share, a 45% drop [7][8].

Core Viewpoint - A securities class action lawsuit has been filed against Zynex, Inc. and its former executives due to a significant overbilling scheme that led to the company's delisting and Chapter 11 bankruptcy filing [1][2]. Summary of Allegations - The lawsuit alleges that Zynex engaged in a predatory "oversupplying" scheme, misleading investors about the legitimacy of its revenue growth [2][3]. - The complaint claims that Zynex shipped excessive medical supplies, such as up to 128 electrode pairs per month, to inflate billings to payors [6]. - It is alleged that Zynex lacked effective internal controls to prevent manipulation of supply orders and billing data [6]. Financial Impact - Zynex's largest payor, Tricare, suspended all payments in early 2025, and the company was forced to forfeit over $85 million to resolve fraud allegations [6]. - Following the exposure of these practices, Zynex filed for Chapter 11 bankruptcy and was delisted from the Nasdaq, resulting in a near-total loss for common equity holders [6]. Legal Proceedings - The lawsuit, Beidel v. Sandgaard, was filed in the U.S. District Court for the District of Colorado, covering the Class Period from February 25, 2021, to December 15, 2025 [2][4]. - Former CEO Thomas Sandgaard and former COO Anna Lucsok were indicted for health care and securities fraud on January 21, 2026 [6]. Important Dates - Investors who purchased Zynex common stock during the Class Period have until April 21, 2026, to request appointment as Lead Plaintiff [4]. Whistleblower Information - Individuals with non-public information regarding Zynex are encouraged to consider their options to assist in the investigation or utilize the SEC Whistleblower program, which offers rewards of up to 30 percent of any successful recovery [4].

ZYXIQ SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026 Accessibility Statement Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partne ...